products /


Medical Advanced Predictability Suite

Empowering Clinical Decision-Making through AI-Driven Insights

In the dynamic world of healthcare, the precision and timeliness of clinical decisions are pivotal for patient outcomes.

With this understanding, we introduce the Medical Advanced Predictability Suite (MAPS), an innovative collection of tools that revolutionizes healthcare delivery and decision-making support. MAPS integrates the advanced capabilities of Business Intelligence (BI) and Artificial Intelligence (AI) to provide a proactive, intelligent dashboard that not only identifies but anticipates clinical events, ensuring compliance with medical guidelines and facilitating early detection of chronic and degenerative diseases.

Our approach
The Synergy of AI and Clinical Decision Support

Our expertise in blending AI with clinical decision-making processes positions MAPS as a transformative force in healthcare analytics. Utilizing claims and electronic health records, MAPS applies our proprietary algorithms and deep learning models to handle diverse data inputs efficiently. This flexibility ensures MAPS’s relevance across different healthcare environments.

Explainability: At the Core of MAPS

Transparency and understanding in AI-driven predictions are critical.

MAPS distinguishes itself by offering:

Confidence Indicators

Accompanying each prediction with a reliability score, increasing trust in the AI system.

Explanation Mechanism

Our AI models are transparent, providing clear insights into their predictive logic. This clarity is vital for clinician adoption and meets regulatory standards, effectively bridging the gap between AI innovations and clinical application.

The evolutive nature of MAPS

Continuous Monitoring and Enhancement

MAPS evolves by learning from its performance, ensuring accuracy and relevance.

Bias Detection and Mitigation

It proactively identifies and corrects biases, promoting equitable healthcare outcomes.

Adaptive Retraining

MAPS undergoes periodic updates to stay ahead of healthcare advancements, tailoring its predictions to specific patient groups or healthcare settings.

A suite of Business Intelligence and Artificial Intelligence solutions allowing

take advanced decisions through an intelligent dashboard

clinical events detection to improve workflows

detection of chronic and degenerative disease deterioration


Real-time alerts for critical clinical events, enhancing proactive healthcare interventions.

Advanced predictive models for managing disease progression and anticipating patient care needs.

Identifies patients at risk of complex healthcare journeys, enabling targeted, effective interventions.

Real Time Alerts
Early Warning Scores
Clinical Guidelines Matching

Human in the loop approaches
Global and Local Explanations
Confidence indication for every prediction

Disease Progression Forecasting
Disease Pathways Identification
Patient Complexity Index

Post-deployment Monitoring
Bias detecting and debiasing
Retraining Capabilities

Impact and benefits

MAPS transcends being merely a technological tool; it is a pledge towards enhancing patient safety and the efficiency of healthcare delivery. By offering predictive insights and actionable intelligence, MAPS streamlines healthcare operations and promotes a more patient-centered care model. With MAPS, healthcare providers can:

As healthcare continues to evolve, MAPS stands as a testament to innovation and a future where decisions are more informed, precise, and centered on patient well-being.

Our commitment is to merge AI with clinical insights, shaping a future where every clinical decision enhances patient care and outcomes.

MAPS Case studies

MAPS (Patient Deterioration Warning Score) "Medical Alert Preventive Score” 170K pediatric patients

The Medical Alert Preventive Score (MAPS) is a tool designed to identify and warn healthcare providers of potential deterioration in pediatric patients. It functions by evaluating various health indicators to generate a score that reflects the risk of a patient’s condition worsening.

The MAPS system has been implemented in a clinical setting encompassing approximately 170,000 pediatric patients. This broad application demonstrates its significance in enhancing patient care by facilitating early intervention strategies. Through its predictive capabilities, MAPS aims to improve outcomes for pediatric patients by enabling healthcare professionals to take preventive measures before a patient’s condition becomes critical.

MAP HYPOXIA predicting “hypoxia 8h in advanced” 30K Patients

The MAP Hypoxia model is a predictive tool designed to forecast the onset of hypoxia in patients up to 8 hours in advance. It has been applied to a cohort of 30,000 patients, showcasing its utility in a clinical setting.

By analyzing various health indicators and patient data, the model calculates the likelihood of a patient developing hypoxia, which is a condition characterized by an insufficient supply of oxygen to the tissues.

The advanced warning provided by the MAP Hypoxia model is critical for healthcare providers, as it allows them to implement early intervention strategies, potentially improving patient outcomes. This predictive capability is particularly valuable in settings where timely detection and response to deteriorating patient conditions are essential for preventing severe complications or fatalities.

MAP DIABETES Insurance Company trial to detect hospitalization 96K patients

The MAP Diabetes project involves a trial conducted by an insurance company aimed at detecting the risk of hospitalization among individuals with diabetes, covering a pool of 96,000 patients.

This initiative utilizes a specialized model to analyze patient data, including health metrics and historical medical records, to identify those at increased risk of requiring hospitalization due to diabetes-related complications. The purpose of this trial is not only to improve patient outcomes by enabling earlier interventions but also to potentially reduce healthcare costs associated with emergency hospital admissions.

By predicting hospitalization events before they occur, healthcare providers can offer targeted care and management strategies to patients, thus enhancing the quality of care and supporting better health management practices for individuals with diabetes. This trial represents a significant step towards proactive healthcare delivery and emphasizes the role of predictive analytics in transforming patient care strategies.

MAP OXYGEN THERAPY detection on COVID patients up to 72h 7k patients

The MAP Oxygen Therapy project is focused on detecting the need for oxygen therapy in COVID-19 patients up to 72 hours in advance, involving a cohort of 7,000 patients. This initiative uses a predictive model to analyze various health indicators and patient data to identify individuals who are likely to require oxygen support within the next three days.

The early detection capability of this model aims to enhance patient care by allowing healthcare providers to prepare and administer oxygen therapy in a timely manner, potentially improving the outcomes for patients with COVID-19. This approach underscores the importance of predictive health analytics in managing infectious diseases and highlights efforts to optimize treatment strategies and resource allocation for affected patients.

Identifying anomalous clinical courses during the screening phase of breast cancer to proactively pinpoint high-risk cases

This approach has been applied to a group of 1,500 women. An anomalous clinical course is characterized by one or more of the following criteria:

  • A suspicious mammogram result, classified as BI-RADS category 3 or higher
  • The patient undergoing a breast echography
  • The patient undergoing a breast MRI
  • The patient undergoing a breast biopsy
  • The patient undergoing a breast fine needle aspiration

This methodology aims to enhance early detection strategies by closely monitoring and analyzing cases that exhibit these specific indicators. The objective is to ensure that individuals who show signs of potentially high-risk developments receive timely and appropriate follow-up care, thereby improving the chances of successful treatment outcomes.

one step forward

This initiative represents a targeted effort to refine breast cancer screening processes and improve healthcare outcomes through early intervention.


Healthcare Entity Resource Optimization
AIO is advancing the scope of operational efficiency through its AI-powered platform, Hero...


Clinical Interoperability
CIP serves as the foundational element for healthcare providers seeking to navigate the complexities of clinical data with ease and precision.


Clinical Dashboard
ACD facilitates the acquisition and normalization of medical data and supports patient care with advanced alarms and alerts.

Angel Suite

Unified Platform for Global Healthcare
Angel Technology is at the forefront of transforming home healthcare through our extensive range of telehealth, telemedicine, and telecare solutions.